Company intelligence / Profile preview

Nura Teethcare

Ownership: Private
Development stage: Commercial

Overview

Nura Teethcare offers a mineralizing toothpaste powered by 12% hydroxyapatite (HAP), the highest known concentration in the world. Independent testing by the University of Milan demonstrated that it repairs enamel and dentin more than twice as effectively as leading fluoride toothpastes. The product is designed to rebuild, whiten, and protect teeth without harsh abrasives or chemicals. Clinical results show significant improvements in enamel stiffness and dentin occlusion after one week of use.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (toothpaste/mineralizing paste)Device (toothbrushes, floss)
Industry: Consumable Medical Devices

Drug pipeline

1 asset

Nura Mineralising Paste

Commercial

Indications: Dental sensitivity, Enamel remineralization

Partnerships

University of Milan (product development/testing)

Beyond the preview

Go deeper on Nura Teethcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nura Teethcare.

Explore the full profile